Early response to benralizumab in Canadian patients with severe eosinophilic asthma: Interim results from a prospective observational cohort

Author:

Noorduyn Stephen G.12,Kayaniyil Sheena1,Lancaster Brett1,Dorscheid Delbert3ORCID,Tourin Olga4,Walker Brandie5,Thawer Amin6,Ramesh Warren7,Khan Irfan8,Kim Harold910,Sussman Gordon11,Mbuagbaw Lawrence2,Penz Erika12ORCID

Affiliation:

1. Department of Medical Affairs, AstraZeneca Canada, Mississauga, Ontario, Canada

2. Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada

3. Center for Heart Lung Innovation, St. Paul ‘s Hospital, Vancouver, British Columbia, Canada

4. U-Breathe Clinic, Calgary, Alberta, Canada

5. Health Research and Innovation Centre, University of Calgary, Calgary, Alberta, Canada

6. Peak Medical Group, Red Deer, Alberta, Canada

7. Edmonton Respiratory Consultants, Edmonton, Alberta, Canada

8. North Bay Regional Health Centre, North Bay, Ontario, Canada

9. Division of Clinical Immunology and Allergy, Western University, London, Ontario, Canada

10. Department of Medicine, McMaster University, Hamilton, Ontario, Canada

11. Gordon Sussman Clinical Research Inc, Toronto, Ontario, Canada

12. Division of Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Publisher

Informa UK Limited

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Validity and Responsiveness of EQ-5D in Asthma: A Systematic Review and Meta-analysis;The Patient - Patient-Centered Outcomes Research;2024-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3